2025-09-14 - Analysis Report
Okay, here's an analysis of Albemarle Corp (ALB) based on the information you've provided.  I'll follow your structure, providing data, then analysis, in English.

**Report on Albemarle Corp (ALB)**

**0. Overview**

Albemarle Corp (ALB) is a specialty chemicals company with leading positions in lithium, bromine, and catalysts.

**1. Performance vs. S&P 500 (VOO)**

*   **Cumulative Return (ALB):** -3.40%
*   **Cumulative Return (VOO):** 89.18%
*   **Absolute Divergence:** -197.0
*   **Relative Divergence:** 0.2

**Analysis:** ALB has significantly underperformed the S&P 500.  The negative divergence indicates substantial underperformance, with the relative divergence suggesting it's near the lower end of its historical divergence range.

**Alpha, Beta Analysis (Selected Periods)**

| Year       | CAGR     | MDD      | Alpha     | Beta | Cap(B) |
| :---------- | :------- | :------- | :-------- | :--- | :------- |
| 2015-2017  | -4.0%    | 0.0%     | -6.0%     | 2.1  | 15.1    |
| 2016-2018  | -31.0%   | 57.3%    | -27.0%    | -0.0 | 9.1     |
| 2017-2019  | -26.0%   | 57.3%    | -49.0%    | -0.0 | 8.6     |
| 2018-2020  | 104.0%   | 62.7%    | 77.0%     | -0.0 | 17.4    |
| 2019-2021  | 214.0%   | 62.7%    | 165.0%    | -0.1 | 27.5    |
| 2020-2022  | 187.0%   | 75.6%    | 181.0%    | -0.0 | 25.5    |
| 2021-2023  | -32.0%   | 77.5%    | -52.0%    | 0.5  | 17.0    |
| 2022-2024  | -145.0%  | 77.5%    | -172.0%   | 0.9  | 10.1    |
| 2023-2025  | -244.0%  | 77.5%    | -298.0%   | 0.4  | 8.9     |

**Analysis:**

*   **Variable Performance:** The CAGR (Compound Annual Growth Rate) shows very volatile performance over different periods, with significant negative returns recently.
*   **High MDD:** The Maximum Drawdown (MDD) is consistently high, indicating substantial risk and volatility.
*   **Alpha:** Alpha is largely negative recently, meaning ALB has underperformed its benchmark on a risk-adjusted basis.
*   **Beta:** Beta fluctuates, suggesting varying degrees of correlation with the market.  The recent positive betas mean that recently ALB has been more volatile than the market (S&P 500).
*   **Capitalization:** The Market Cap (Cap(B)) has decreased over time.

**2. Recent Stock Price Movements**

*   **Current Price:** 75.98
*   **Previous Close:** 74.645
*   **Change:** 1.79
*   **5-day Moving Average:** 75.786
*   **20-day Moving Average:** 80.2325
*   **60-day Moving Average:** 73.9172

**Analysis:**

*   The price increased compared to the previous close.
*   The 5-day moving average is below the 20-day moving average, suggesting a short-term downtrend.
*   The price is above the 60-day moving average, which might indicate medium-term support.

**3. Technical Indicators**

*   **Market Risk Indicator (MRI):** 0.3233 (Low Risk)
*   **RSI:** 41.18
*   **PPO:** -1.586
*   **Hybrid Signal:** cash_69%_Sell 0.8% of holdings (4 shares - Caution - MRI:0.33)
*   **Delta_Previous_Relative_Divergence (20-day):** -3.2 (Negative - Short-term Decline)
*   **Expected Return (%):** 4994.1%

**Analysis:**

*   **MRI:** The Market Risk Indicator is in the "Low Risk" range, which is contradictory to what the recent earning data suggest.
*   **RSI:** An RSI of 41.18 suggests the stock is not yet oversold, but is approaching that level.
*   **PPO:** The negative PPO suggests the stock is in a short-term downtrend.
*   **Hybrid Signal:** The hybrid signal recommends a cautious approach, suggesting selling a small portion of holdings and increasing the cash position.
*   **Delta_Previous_Relative_Divergence:** The negative change in relative divergence confirms the recent short-term downward trend.
*   **Expected Return:** The extremely high "Expected Return" should be viewed with skepticism.  It represents a very optimistic, long-term projection compared to the S&P 500, and may not be realistic.
*   **Price Change:** The increase in price compared to the previous close may be a short term rebound.

**4. Recent News & Significant Events:**

*   **Positive Headlines:** Recent headlines suggest some positive momentum, with Albemarle outperforming the broader market and earnings beating expectations. Mentions in industry outlooks are also generally favorable.
*   **Themes:** The news articles emphasize earnings beats, cost-cutting measures, and positive price target adjustments. Demand worries are also mentioned, suggesting some uncertainty.

**4-2. Analyst Opinions:**

*   **Consensus:** Hold
*   **Mean Rating:** 2.64 (~Hold)
*   **Target Price:** 85.97 (average)
*   **Range:** 58.00 (low) - 200.00 (high)

**Analysis:**

*   Analysts have a consensus "Hold" rating, with a mean rating aligning with this recommendation.
*   The average target price suggests a potential upside from the current price. However, the wide range in target prices indicates significant uncertainty among analysts.

**5. Recent Earnings Analysis:**

| Date       | EPS   | Revenue    |
| :---------- | :----- | :---------- |
| 2025-08-04 | -0.16 | 1.33 B$    |
| 2025-04-30 | 0     | 1.08 B$    |
| 2024-11-06 | -9.45 | 1.35 B$    |
| 2024-07-31 | -1.96 | 1.43 B$    |
| 2025-08-04 | -1.96 | 1.43 B$    |

**Analysis:**

*   **EPS Volatility:** Earnings per share (EPS) has been highly volatile and largely negative recently.
*   **Revenue Fluctuations:** Revenue has also fluctuated, indicating potential challenges in maintaining consistent growth.

**6. Financial Information**

**Revenue and Profitability**

| Quarter      | Revenue   | Profit Margin |
| :------------ | :--------- | :------------- |
| 2025-06-30   | $1.33B    | 14.80%         |
| 2025-03-31   | $1.08B    | 14.51%         |
| 2024-12-31   | $1.23B    | 11.22%         |
| 2024-09-30   | $1.35B    | -7.68%         |
| 2024-06-30   | $1.43B    | -0.74%         |

**Capital and Profitability**

| Quarter      | Equity    | ROE      |
| :------------ | :-------- | :------- |
| 2025-06-30   | $10.24B   | 0.22%    |
| 2025-03-31   | $10.03B   | 0.41%    |
| 2024-12-31   | $9.96B    | 0.76%    |
| 2024-09-30   | $10.24B   | -10.44%  |
| 2024-06-30   | $11.22B   | -1.68%   |

**Analysis:**

*   **Profit Margin:**  Profit margins have fluctuated significantly, with negative margins in some recent quarters. The last two quarters show some recovery.
*   **Equity:** Equity has generally been declining, potentially indicating financial strain.
*   **ROE:**  Return on Equity (ROE) has been low and negative in some periods, indicating poor profitability relative to equity.

**7. Overall Assessment**

Albemarle Corp (ALB) faces significant challenges. While recent news headlines and the small single-day price increase are encouraging, the company has underperformed the market substantially, exhibiting high volatility and negative alpha. Recent earnings have been weak, with fluctuating revenue and negative EPS. Profitability metrics (profit margin and ROE) also show inconsistencies and periods of negative performance.

The analyst consensus is "Hold," but target price ranges vary widely. Technical indicators suggest caution, and the hybrid signal recommends reducing holdings. While the long-term "Expected Return" is very high, it should be viewed with skepticism given the company's recent performance.

**In summary, while there are some positive signs, Albemarle presents a high-risk investment profile based on the provided data.**
